Looking for Equity based startup Advisor’s, Consultants and Board Directors to help Volmine Inc obtain funding and bring our Anti-bacterial clay mineral to the Global marketplace. Our mines have a proven 60 million tons drilled with assay reports and an estimated 3 billion tons on the mine property located in the United States. The mines are a Natural Clay Mineral that is extremely Anti-bacterial towards pathogenic bacteria when hydrated. Could be used therapeutically in animal feeds helping to reduce or replace antibiotics for swine, poultry, ruminants, aquaculture, natural biocide/crop protection, foliar spraying for sunburn protection, farm soil remediation, animal supplements and as soil amendment with its cat-ion exchange properties that have mimicked plant growth hormone results in corn and over 60%growth increases in garlic
Scientists working with Arizona State University have been researching our clay for 4 years and test results show that it kills 100% of the pathogenic disease promoting bacteria within a 24 hour period. Research is continuing on our clays ability to kill and eliminate many more pathogenic bacteria. Research results will be released in the near future in Scientific Journals for you to read. The following pathogenic bacteria have already been proven to be completely killed.
Pseudomonas aeruginosa,
Staphylococcus aureus,
Escherichia coli,
Salmonella,
Methicillin-resistant Staphylococcus aureus (MRSA)
and Extended-Spectrum beta-lactamase (ESBL)
Scientists working with Arizona State University have been researching our clay for 4 years and test results show that it kills 100% of the pathogenic disease promoting bacteria within a 24 hour period. Research is continuing on our clays ability to kill and eliminate many more pathogenic bacteria. Research results will be released in the near future in Scientific Journals for you to read. The following pathogenic bacteria have already been proven to be completely killed.
Pseudomonas aeruginosa,
Staphylococcus aureus,
Escherichia coli,
Salmonella,
Methicillin-resistant Staphylococcus aureus (MRSA)
and Extended-Spectrum beta-lactamase (ESBL)